14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
Entrepreneurs' relief (ER) provides for a lower rate of capital gains tax (10 percent) to be paid wh...
Read More >
In this issue of UK Employment Flash, we examine the latest employment law developments, news and in...
Read More >
Seyfarth Synopsis: In Sellars v. CRST Expedited, Inc. Case No. C15-117-LTS (July 15, 2019), the Nort...
Read More >
Join us virtually for a Latin American Compliance Conference where senior government officials, indu...
Read More >
Brent A. Morowitz, of counsel in the Corporate and Securities Practice Group of Pepper, was intervie...
Read More >
After weeks of Updates detailing the disastrous effects of COVID-19 on the lodging industry, this we...
Read More >